Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis.

Cancer treatment and research communications - 1 Jan 2021

Takahara Yutaka, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Taku, Mizuno Shiro

Abstract excerpt

OBJECTIVE: Lung cancer patients presenting with osteoblastic bone metastases at the first visit is rare. We investigated the clinical characteristics and gene mutation rate of non-small cell lung cancer patients with osteoblastic bone metastases at the time of the initial diagnosis. MATERIALS AND METHODS: We retrospectively screened newly diagnosed non-small cell lung cancer patients with osteoblastic bone...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Neoplasms

Share to Carcinoma, Non-Small-Cell Lung

Share to Lung Neoplasms

Share to Mutation

Share to Neoplasm Metastasis

Share to Osteoblasts

Source

Identifiers

PMID: 34325210
DOI: 10.1016/j.ctarc.2021.100440

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis.PMID 34325210Read ↗

Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib.Semantic proximity Read ↗

Assessing EGFR-mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy.Semantic proximity Read ↗

Osteoblastic reaction in non-small cell lung carcinoma and its association to epidermal growth factor receptor tyrosine kinase inhibitors response and prolonged survival.Semantic proximity Read ↗

Driver gene mutations and clinical features predict bone metastasis risk in NSCLC: a logistic regression model.Semantic proximity Read ↗

Osteoblastic bone lesions developing during treatment with erlotinib indicate major response in patients with non-small cell lung cancer: a brief report.Semantic proximity Read ↗

[Impact of bone metastasis on the prognosis of lung adenocarcinoma patients treated with third-generation EGFR-TKI and the underlying mechanisms].Semantic proximity Read ↗

Association of mutation profiles with metastasis in patients with non-small cell lung cancerSemantic proximity Read ↗

Clinical characteristics of miliary pulmonary metastases in non-small cell lung cancer.Semantic proximity Read ↗

Incidence, Survival, And Associated Factors Estimation In Osteosarcoma Patients With Lung Metastasis: A Single-Center Experience of 11 Years In Tianjin, ChinaSemantic proximity Read ↗

Rapidly progressive squamous cell lung cancer with MET exon 14 skipping mutation metastasized to atypical bone sites - a case report.Semantic proximity Read ↗

Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations.Semantic proximity Read ↗

Prediction of skeletal-related events in patients with non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.